Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20681 | 449 | 27.2 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
20681 | 1 | CELIPROLOL//PERINDOPRIL THERAPEUTIC USE//1 BETA ADRENERGIC RECEPTOR | 449 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CELIPROLOL | authKW | 1007454 | 9% | 37% | 40 |
2 | PERINDOPRIL THERAPEUTIC USE | authKW | 136013 | 0% | 100% | 2 |
3 | 1 BETA ADRENERGIC RECEPTOR | authKW | 68007 | 0% | 100% | 1 |
4 | 2 DIMENSIONAL NUCLEAR MAGNETIC RESONANCE 2D NMR | authKW | 68007 | 0% | 100% | 1 |
5 | ABT KARDIOL KLIN POLIKLIN INNERE MED | address | 68007 | 0% | 100% | 1 |
6 | AGONIST ACTIVITY PARTIAL | authKW | 68007 | 0% | 100% | 1 |
7 | ATENOLOL CLINICAL STUDIES | authKW | 68007 | 0% | 100% | 1 |
8 | CAS 56980 93 9 | authKW | 68007 | 0% | 100% | 1 |
9 | CATEDRA QUIM ORGAN 1 CATEDRA QUIM ANALIT | address | 68007 | 0% | 100% | 1 |
10 | CELIPROLOL 24 HOUR BLOOD PRESSURE MONITORING | authKW | 68007 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 3003 | 33% | 0% | 146 |
2 | Pharmacology & Pharmacy | 2691 | 45% | 0% | 204 |
3 | Medicine, General & Internal | 689 | 19% | 0% | 86 |
4 | Peripheral Vascular Diseases | 461 | 10% | 0% | 45 |
5 | Chemistry, Medicinal | 88 | 5% | 0% | 22 |
6 | Medicine, Research & Experimental | 50 | 5% | 0% | 23 |
7 | Physiology | 7 | 2% | 0% | 11 |
8 | Toxicology | 3 | 2% | 0% | 7 |
9 | Primary Health Care | 1 | 0% | 0% | 1 |
10 | Respiratory System | 0 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT KARDIOL KLIN POLIKLIN INNERE MED | 68007 | 0% | 100% | 1 |
2 | CATEDRA QUIM ORGAN 1 CATEDRA QUIM ANALIT | 68007 | 0% | 100% | 1 |
3 | ST MARYS HOSP RENAL MEDRENAL UNIT | 68007 | 0% | 100% | 1 |
4 | ABT INTERVENT KARDIOL | 22668 | 0% | 33% | 1 |
5 | CHAIR ANGIOL | 17000 | 0% | 25% | 1 |
6 | LANG EDUC | 17000 | 0% | 25% | 1 |
7 | PHARMACEUT MED COMMUN | 11333 | 0% | 17% | 1 |
8 | HLTH FITNESS MANAGEMENT | 6181 | 0% | 9% | 1 |
9 | ANGIOL HEMOSTASE | 5665 | 0% | 8% | 1 |
10 | COURSE CLIN PHARM | 5229 | 0% | 8% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 16091 | 11% | 0% | 51 |
2 | BRITISH JOURNAL OF CLINICAL PRACTICE | 11868 | 4% | 1% | 19 |
3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 4994 | 4% | 0% | 18 |
4 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 4413 | 5% | 0% | 23 |
5 | AMERICAN HEART JOURNAL | 4255 | 7% | 0% | 30 |
6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 4085 | 4% | 0% | 17 |
7 | WIENER MEDIZINISCHE WOCHENSCHRIFT | 4075 | 1% | 1% | 6 |
8 | ACTA MEDICA SCANDINAVICA | 3261 | 2% | 0% | 10 |
9 | ANGIOLOGY | 2495 | 3% | 0% | 13 |
10 | CARDIOVASCULAR DRUGS AND THERAPY | 2235 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DUNN, CJ , SPENCER, CM , (1995) CELIPROLOL - AN EVALUATION OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF HYPERTENSION AND ANGINA-PECTORIS.DRUGS & AGING. VOL. 7. ISSUE 5. P. 394-411 | 53 | 74% | 16 |
2 | MILNE, RJ , BUCKLEY, MMT , (1991) CELIPROLOL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR-DISEASE.DRUGS. VOL. 41. ISSUE 6. P. 941-969 | 54 | 76% | 58 |
3 | RIDDELL, JG , SHANKS, RG , BROGDEN, RN , (1987) CELIPROLOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND ITS THERAPEUTIC USE IN HYPERTENSION AND ANGINA-PECTORIS.DRUGS. VOL. 34. ISSUE 4. P. 438-458 | 41 | 82% | 47 |
4 | NORRIS, RJ , (1988) ANTIHYPERTENSIVE THERAPY WITH CELIPROLOL - A NEW CARDIOSELECTIVE BETA-BLOCKER.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 61. ISSUE 5. P. C14-C22 | 27 | 93% | 4 |
5 | PARAVASTU, SCV , MENDONCA, DA , DA SILVA, A , (2013) BETA BLOCKERS FOR PERIPHERAL ARTERIAL DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 20 | 49% | 4 |
6 | PARAVASTU, SCV , MENDONCA, D , DA SILVA, A , (2008) BETA BLOCKERS FOR PERIPHERAL ARTERIAL DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 16 | 59% | 10 |
7 | YAGENSKY, AV , BARSUKOV, BP , (1992) THE 3RD-GENERATION OF BETA-BLOCKERS - NEW POTENTIALITIES.KARDIOLOGIYA. VOL. 32. ISSUE 11-12. P. 98-103 | 27 | 61% | 0 |
8 | LAMON, KD , (1991) CLINICAL SAFETY AND EFFICACY OF CELIPROLOL.AMERICAN HEART JOURNAL. VOL. 121. ISSUE 2. P. 683-687 | 21 | 81% | 9 |
9 | LANE, DA , LIP, GYH , (2013) TREATMENT OF HYPERTENSION IN PERIPHERAL ARTERIAL DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 27 | 29% | 1 |
10 | CLEOPHAS, TJ , VANTLEVEN, M , KAUW, FH , REMMERT, HP , KUIJPER, A , ZWINDERMAN, K , (1995) CELIPROLOL VS PROPRANOLOL IN UNSTABLE ANGINA-PECTORIS - A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY.ANGIOLOGY. VOL. 46. ISSUE 2. P. 137-144 | 13 | 93% | 3 |
Classes with closest relation at Level 1 |